Health Care

4529 posts
Ai gen brain scan

FDA approval not enough to revive local Telix Pharma bulls as stock pulls back again

While it’s generally a true maxim that for ASX-listed healthcare companies US FDA approvals tend to be a major upside catalyst, this week
Cancer concept

Prescient Therapeutics nears a pivotal moment as PTX-100 Phase 2a trial hits key milestone

As cancer rates around the world climb for a range of reasons, one of the most active frontiers in the oncology space remains

Argenica Therapeutics’ concussion data selected for international neurotrauma congress

Argenica Therapeutics' recent preclinical concussion study has been selected for oral presentation at an international meeting…
Medical project manager using a laptop

PYC Therapeutics doses first patient in OLE study supporting kidney disease candidate

PYC Therapeutics has dosed the first patient in a Part D open-label extension (OLE) of an…

LTR Pharma expands men’s health portfolio with KYZATREX pilot

LTR Pharma has entered into an exclusive pilot agreement to introduce KYZATREX oral testosterone capsules in…

4DMedical posts FY26 revenue growth as commercial deployment ramps up

4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major…

Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate

Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the…

Ramsay Health Care profit surges as Australian hospitals drive FY26 turnaround

Ramsay Health Care reports a sharp FY26 profit increase, with stronger Australian hospital activity, improved margins…

Pro Medicus signs $25M contract with US-based Valley Health

Pro Medicus' US subsidiary Visage Imaging has signed a seven-year, $25 million contract with Valley Health…

Pro Medicus posts 130% profit surge as forward contract book hits $1.34b

Pro Medicus posts a 130.3% rise in FY26 NPAT to $265.3m as revenue reaches $261.7m and…